Dr. Satinder K. Singh, PhD, is a “researcher-in-residence” on sabbatical leave from Yale University School of Medicine, where she is an Associate Professor of Cellular and Molecular Physiology. She has had a long-standing interest in elucidating the molecular mechanisms underlying neurological and neuropsychiatric diseases, particularly epilepsy, autism, and obsessive-compulsive disorder (OCD). This passion is reflected in her neuroscience research at Yale, where she focuses on the structure, function, regulation, and pharmacology of neuronal signaling proteins implicated in these debilitating diseases. Her ultimate goal is to help pave the road toward rational therapeutic interventions.
Dr. Singh’s desire to work at CURE stems from her interest in being exposed to the grant funding process, particularly at an organization whose mission she cares about deeply. Dr. Singh has been capitalizing on her knowledge of neuroscience, neuropsychopharmacology, and biochemistry to collaborate with other Research Team members in advancing CURE’s scientific endeavors as well as its critical role in the broader epilepsy community. She has found her experiences at CURE to be extremely rewarding since she herself suffers from epilepsy and so has confronted the physical and emotional trauma of violent tonic-clonic seizures, endured the dreadful side effects of multiple anticonvulsants, undergone partially-successful resective neurosurgery, and encountered needless social stigma. Nevertheless, she also views her illness as having afforded her the unique opportunity to bridge two worlds, as a neuroscientist who also happens to be a patient.